ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

BIOR Biora Therapeutics Inc

0.74
0.009 (1.23%)
Pre Market
Last Updated: 22:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Biora Therapeutics Inc BIOR NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.009 1.23% 0.74 22:00:00
Open Price Low Price High Price Close Price Previous Close
0.731
more quote information »

Recent News

Date Time Source Heading
06/5/202422:00GLOBEBiora Therapeutics to Present Clinical Data on Device..
30/4/202422:00GLOBEBiora Therapeutics Announces Completion of..
08/4/202422:00GLOBEBiora Therapeutics Announces New Patent Covering its BioJet™..
04/4/202423:00GLOBEBiora Therapeutics Achieves Positive Interim Results for..
04/4/202407:05GLOBEBiora Therapeutics Announces Closing of $6 Million..
01/4/202423:00GLOBEBiora Therapeutics Announces $6 Million Registered Direct..
27/3/202407:05GLOBEBiora Therapeutics Provides Corporate Update and Reports..
26/3/202422:21IHMARKETNEWSU.S. Index Futures on the Rise, Oil Prices Show Stability
18/3/202423:00GLOBEBiora Therapeutics to Report Fourth Quarter and Full Year..
11/3/202423:11EDGAR2Form 8-K - Current report
11/3/202423:00GLOBEBiora Therapeutics Further Reduces Net Debt and Monetizes..
27/2/202400:00GLOBEBiora Therapeutics Announces Successful Completion of..
16/2/202408:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202408:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202406:43EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/2/202400:00GLOBEBiora Therapeutics Announces Participation in Canaccord..
23/1/202400:00GLOBEBiora Therapeutics Announces Participation in Fireside Chat..
17/1/202409:20EDGAR2Form 8-K - Current report
17/1/202400:00GLOBEBiora Therapeutics Provides Outlook for 2024
09/1/202400:00GLOBEBiora Therapeutics Announces Initiation of Phase 1 Clinical..
03/1/202400:00GLOBEBiora Therapeutics Progresses Research Collaboration for the..
02/1/202416:15EDGAR2Form EFFECT - Notice of Effectiveness
23/12/202309:19EDGAR2Form S-3 - Registration statement under Securities Act of..
21/12/202308:35EDGAR2Form SC 13D/A - General statement of acquisition of..
20/12/202300:00GLOBEBiora Therapeutics Announces New Patent for its NaviCap™..
19/12/202300:06EDGAR2Form 8-K - Current report
19/12/202300:00GLOBEBiora Therapeutics Accelerates Debt Reduction and Raises..
16/12/202309:25EDGAR2Form 8-K - Current report
12/12/202300:00GLOBEBiora Therapeutics Announces New Research Collaboration for..
01/12/202322:06EDGAR2Form 8-K - Current report
01/12/202310:53DJNBiora Therapeutics Shares Rise 64% After FDA Clears..
01/12/202309:29DJNBiora Therapeutics Application for Ulcerative Colitis..
01/12/202308:48GLOBEBiora Therapeutics Announces FDA Clearance of IND..
14/11/202308:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202308:05GLOBEBiora Therapeutics Provides Corporate Update and Reports ..
07/11/202300:00GLOBEBiora Therapeutics to Report Third Quarter 2023 Financial..
31/10/202307:05GLOBEBiora Therapeutics Submits Updated IND Application for..
24/10/202308:30GLOBEBiora Therapeutics to Submit Updated IND Application for..
13/10/202321:04EDGAR2Form 8-K - Current report
11/10/202321:01EDGAR2Form 8-K - Current report
07/10/202308:19EDGAR2Form 8-K - Current report
05/10/202323:00GLOBEBiora Therapeutics Presents Data on the BioJet™ Systemic..
25/9/202322:00GLOBEBiora Therapeutics Announces Submission of IND Application..
20/9/202306:15EDGAR2Form SC 13D/A - General statement of acquisition of..
19/9/202322:06EDGAR2Form 8-K - Current report
19/9/202322:00GLOBEBiora Therapeutics Reduces Debt and Largest Shareholder..
11/9/202322:01GLOBEBiora Therapeutics to Present at H.C. Wainwright 25th Annual..
05/9/202322:00GLOBEBiora Therapeutics Progresses its BioJet™ Systemic Oral..
18/8/202306:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/8/202306:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Your Recent History

Delayed Upgrade Clock